Search results for: England
Filter search results
OHE at HTAi Oslo: A New Drug Development Paradigm, and the Effect of NICE Decisions Abroad
19 June 2015
…Devlin (OHE). This poster looks at whether NICE recommendations on the use of a new drug affect recommendations from other bodies in countries outside England and Wales. A basket…
Waiting Time Policies in the Health Sector: What Works?
27 October 2015
…sanctions for non-compliance (for example England and Finland). The guarantees often go hand-in-hand with choice, competition and an increase in supply (for example Denmark, Portugal and the Netherlands). Demand-side policies…
OHE at ISOQOL 2015: Valuing Health-Related Quality of Life
8 December 2015
…2015 from Office of Health Economics In an oral session entitled ‘Health Utilities’, Koonal also presented a comparison of health state valuation data collected in England and the United Arab…
New publication: Using Patient Reported Outcomes to Improve Health Care
21 December 2015
…Keogh (NHS England) adds: “Unravelling the relative utility of different PROMs [patient reported outcome measures] to patients, clinicians or institutions will require rigorous analysis. This book does just that”. To…
What Drives Variations in Relative Effectiveness Across Countries?
31 May 2016
…on breast cancer from England, Spain, and Sweden as a case study, and investigate the reasons why the relative effectiveness of a new drug might vary across healthcare systems. The…
New Publication: EuroQol Protocols for Time Trade-Off Valuation of Health States
8 June 2016
…states, and was used in OHE’s EQ-5D-5L value set for England study. Screenshot from the EQ-VT TTO protocol Source: EuroQol Valuation Technology; ©EuroQol Research Foundation Just published in PharmacoEconomics is…
OHE at PROMs Conference Sheffield 2016: Presentations and Posters
23 June 2016
…Koonal Shah. It compares three EQ-5D values sets: the UK EQ-5D-3L (MVH) value set; the EQ-5D-5L cross walk value set; and the new EQ-5D-5L value set for England. A Comparison…
Dr Francois Maignen joins the OHE team as Head of Operational Research and Data Analysis
7 July 2016
…also holds a MSc in applied statistics (Birkeck College, University of London, England). References: 1. Maignen, F., Hauben, M., Tsintis, P., 2010. Modelling the time to onset of adverse reactions with parametric…
OHE at AES 2016: Early Access Schemes, Equity Adjusted QALYs, Multi-indication Pricing and Formulary Development
2 August 2016
…lessons from the England value-based pricing (VBP) saga in which practical ways of implementing severity and societal impact adjustments to QALYs were identified but rejected; Concluded that moving from listing…